{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T21:52:27Z","timestamp":1744667547892,"version":"3.37.3"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009438","name":"NCNP","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["17lk0201058h0002"],"award-info":[{"award-number":["17lk0201058h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.braindev.2018.07.012","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T19:11:01Z","timestamp":1533150661000},"page":"43-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Renal dysfunction is rare in Fukuyama congenital muscular dystrophy"],"prefix":"10.1016","volume":"41","author":[{"given":"Keiko","family":"Ishigaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terumi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minobu","family":"Shichiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyonobu","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Funatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2018.07.012_b0005","series-title":"Congenital muscular dystrophies","first-page":"31","article-title":"Fukuyama type congenital muscular dystrophy","author":"Osawa","year":"1997"},{"key":"10.1016\/j.braindev.2018.07.012_b0010","series-title":"Translational research in muscular dystrophy","first-page":"1","article-title":"Fukuyama congenital muscular dystrophy: clinical aspects (Chapter 1)","author":"Ishigaki","year":"2015"},{"key":"10.1016\/j.braindev.2018.07.012_b0015","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2018.07.012_b0020","first-page":"431","article-title":"Usefulness of serum cystatin C concentration as renal function marker in patients with Duchenne muscular dystrophy","volume":"35","author":"Minami","year":"2003","journal-title":"No To Hattatsu"},{"key":"10.1016\/j.braindev.2018.07.012_b0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.nmd.2016.07.010","article-title":"Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C","volume":"26","author":"Villa","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2018.07.012_b0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5692\/clinicalneurol.52.211","article-title":"Renal dysfunction is a frequent complication in patients with advanced stage of Duchenne muscular dystrophy (in Japanese)","volume":"52","author":"Matsumura","year":"2012","journal-title":"Rinsho Shinkeigaku (Tokyo)"},{"key":"10.1016\/j.braindev.2018.07.012_b0035","doi-asserted-by":"crossref","first-page":"743","DOI":"10.5692\/clinicalneurol.51.743","article-title":"A longitudinal cause-of-death analysis of patients with Duchenne muscular dystrophy (in Japanese)","volume":"51","author":"Matsumura","year":"2011","journal-title":"Rinsho Shinkeigaku (Tokyo)"},{"year":"2012","series-title":"Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012","author":"Japanese Society of Nephrology","key":"10.1016\/j.braindev.2018.07.012_b0040"},{"key":"10.1016\/j.braindev.2018.07.012_b0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jns.2016.07.036","article-title":"Renal dysfunction can be a common complication in patients with myotonic dystrophy 1","volume":"368","author":"Matsumura","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2018.07.012_b0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.nmd.2015.07.006","article-title":"Treatable renal failure found in non-ambulatory Duchenne muscular dystrophy patients","volume":"25","author":"Motoki","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.braindev.2018.07.012_b0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.braindev.2017.05.008","article-title":"Cardiac involvement in Fukuyama muscular dystrophy is less severe than in Duchenne muscular dystrophy","volume":"39","author":"Yamamoto","year":"2017","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2018.07.012_b0060","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.braindev.2018.07.012_b0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2165\/00002018-199615030-00005","article-title":"ACE inhibitors and the kidney. A risk-benefit assessment","volume":"15","author":"Navis","year":"1996","journal-title":"Drug Saf"},{"key":"10.1016\/j.braindev.2018.07.012_b0070","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/hc4101.096153","article-title":"Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association","volume":"104","author":"Schoolwerth","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.braindev.2018.07.012_b0075","first-page":"720","article-title":"Beneficial and adverse effects of angiotensin converting enzyme inhibitor in patients with severe congestive heart failure associated with Duchenne muscular dystrophy","volume":"47","author":"Ishikawa","year":"1993","journal-title":"IRYO"},{"key":"10.1016\/j.braindev.2018.07.012_b0080","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/ped.12956","article-title":"Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate","volume":"58","author":"Yamazaki","year":"2016","journal-title":"Pediatr Int"},{"key":"10.1016\/j.braindev.2018.07.012_b0085","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00467-005-1827-7","article-title":"Secondary renal Fanconi syndrome caused by valproate therapy","volume":"20","author":"Watanabe","year":"2005","journal-title":"Pediatr Nephrol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760418303437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760418303437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T17:53:14Z","timestamp":1543945994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760418303437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0387760418303437"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2018.07.012","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal dysfunction is rare in Fukuyama congenital muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2018.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Japanese Society of Child Neurology Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}